Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Bando

Showing results (41-50 of 186) with videos related to

Pageof 19
Sort By:
Cancer Chemotherapy and Pharmacology|June 25, 2015
Phase 1 pharmacokinetic study of the oral pan-AKT inhibitor MK-2206 in Japanese patients with advanced solid tumorsToshihiko Doi, Kenji Tamura, Yuko Tanabe, et al.
Cancer Chemotherapy and Pharmacology|April 3, 2020
Phase 1 study of napabucasin, a cancer stemness inhibitor, in patients with advanced solid tumorsAkihito Kawazoe, Yasutoshi Kuboki, Hideaki Bando, et al.
Annals of Surgical Oncology|August 8, 2020
Long-Term Outcome of Patients with Locally Advanced Clinically Unresectable Esophageal Cancer Undergoing Conversion Surgery after Induction Chemotherapy with Docetaxel Plus Cisplatin and 5-FluorouracilTetsuya Abe, Eiji Higaki, Takahiro Hosoi, et al.
Oncogene|January 20, 2018
Distinct dependencies on receptor tyrosine kinases in the regulation of MAPK signaling between BRAF V600E and non-V600E mutant lung cancersHiroshi Kotani, Yuta Adachi, Hidenori Kitai, et al.
Clinical Colorectal Cancer|March 19, 2025
A Phase Two, Single-Arm, Open-Label Study With Dostarlimab Monotherapy in Participants With Untreated Stage II/III dMMR/MSI-H Locally Advanced Rectal Cancer (AZUR-1)Andrea Cercek, Jean-Baptiste Bachet, Jaume Capdevila, et al.
World Journal of Gastroenterology|January 19, 2010
A laterally-spreading tumor in a colonic interposition treated by endoscopic submucosal dissectionHideaki Bando, Hiroaki Ikematsu, Kuang-I Fu, et al.
British Journal of Cancer|April 25, 2019
A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancerHideaki Bando, Yoshinori Kagawa, Takeshi Kato, et al.
Japanese Journal of Clinical Oncology|June 22, 2012
Early clinical outcomes of anal squamous cell carcinoma treated with concurrent chemoradiotherapy with 5-Fluorouracil plus mitomycin C in Japanese patients: experience at a single institutionHironaga Satake, Takayuki Yoshino, Takahide Sasaki, et al.
BMC Cancer|March 23, 2019
Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapyKazuaki Harada, Wataru Okamoto, Sachiyo Mimaki, et al.
BMC Cancer|September 7, 2013
Simultaneous identification of 36 mutations in KRAS codons 61 and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kitHideaki Bando, Takayuki Yoshino, Eiji Shinozaki, et al.
Pageof 19

Showing results (41-50 of 186) with videos related to

Sort By:
Pageof 19
Cancer Chemotherapy and Pharmacology|June 25, 2015
Phase 1 pharmacokinetic study of the oral pan-AKT inhibitor MK-2206 in Japanese patients with advanced solid tumorsToshihiko Doi, Kenji Tamura, Yuko Tanabe, et al.
Cancer Chemotherapy and Pharmacology|April 3, 2020
Phase 1 study of napabucasin, a cancer stemness inhibitor, in patients with advanced solid tumorsAkihito Kawazoe, Yasutoshi Kuboki, Hideaki Bando, et al.
Annals of Surgical Oncology|August 8, 2020
Long-Term Outcome of Patients with Locally Advanced Clinically Unresectable Esophageal Cancer Undergoing Conversion Surgery after Induction Chemotherapy with Docetaxel Plus Cisplatin and 5-FluorouracilTetsuya Abe, Eiji Higaki, Takahiro Hosoi, et al.
Oncogene|January 20, 2018
Distinct dependencies on receptor tyrosine kinases in the regulation of MAPK signaling between BRAF V600E and non-V600E mutant lung cancersHiroshi Kotani, Yuta Adachi, Hidenori Kitai, et al.
Clinical Colorectal Cancer|March 19, 2025
A Phase Two, Single-Arm, Open-Label Study With Dostarlimab Monotherapy in Participants With Untreated Stage II/III dMMR/MSI-H Locally Advanced Rectal Cancer (AZUR-1)Andrea Cercek, Jean-Baptiste Bachet, Jaume Capdevila, et al.
World Journal of Gastroenterology|January 19, 2010
A laterally-spreading tumor in a colonic interposition treated by endoscopic submucosal dissectionHideaki Bando, Hiroaki Ikematsu, Kuang-I Fu, et al.
British Journal of Cancer|April 25, 2019
A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancerHideaki Bando, Yoshinori Kagawa, Takeshi Kato, et al.
Japanese Journal of Clinical Oncology|June 22, 2012
Early clinical outcomes of anal squamous cell carcinoma treated with concurrent chemoradiotherapy with 5-Fluorouracil plus mitomycin C in Japanese patients: experience at a single institutionHironaga Satake, Takayuki Yoshino, Takahide Sasaki, et al.
BMC Cancer|March 23, 2019
Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapyKazuaki Harada, Wataru Okamoto, Sachiyo Mimaki, et al.
BMC Cancer|September 7, 2013
Simultaneous identification of 36 mutations in KRAS codons 61 and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kitHideaki Bando, Takayuki Yoshino, Eiji Shinozaki, et al.
Pageof 19